Written by Jill McNair | jmcnair@ciscrp.org
In December 2020, CISCRP announced that it is providing plain language communication consulting and services to companies involved in “Operation Warp Speed.” As readers may know, Operation Warp Speed is a public-private partnership started by the US government to help in the development, manufacturing, and distribution of COVID-19 vaccines. CISCRP has pledged to volunteer our knowledge and resources to assist Operation Warp Speed sponsors. We are pleased to be providing our services to AstraZeneca, Janssen Pharmaceuticals, Moderna, and Pfizer.
For more than 10 years, CISCRP has been translating scientific clinical trial results information into plain language for patients and the public around the world. To deliver on our pledge, CISCRP is continuing to do this by assisting Operation Warp Speed vaccine sponsors in a variety of ways. This includes:
- developing, producing, and distributing plain language trial results summaries
- translating scientific medical journal articles into plain language
- preparing plain language content to be communicated in print and digital formats
Oxford PharmaGenesis, a global provider of medical, regulatory, and scientific writing, will also be volunteering its services together with CISCRP to support Operation Warp Speed sponsors.
The demand from the public, patients, and the healthcare community for plain language information about the results of COVID-19 vaccine trials is high. Health officials and Operation Warp Speed sponsors also believe that providing clear information and results is necessary to gaining public trust and support for other vaccination programs in the future.
Said Ken Getz, CISCRP’s founder and board chair: “Given the incredible time and resource pressures that Operation Warp Speed vaccine sponsors are facing, CISCRP decided to donate staff time and expertise, its editorial panel of patients, and print production and distribution costs. We’re very pleased to be collaborating with so many COVID-19 vaccine sponsors. And in the process, CISCRP can ensure consistent, high quality, and compliant practices across sponsor companies.”
